In an effort to establish new candidates with improved analgesic and anti-inflammatory activities and lower ulcerogenic risk, a series of thiazolo[3,2-b]-1,2,4-triazole-5(6H)-one derivatives of ibuprofen were synthesized. All compounds were evaluated for their in vivo anti-inflammatory and analgesic activities in mice. Furthermore, the ulcerogenic risks of the compounds were determined. In general
为了建立具有更好的止痛和抗炎活性并降低致溃疡风险的新候选药物,
布洛芬的一系列
噻唑并[3,2 - b ] -
1,2,4-三唑-5(6 H)-one衍
生物被合成。评价所有化合物在小鼠中的体内抗炎和止痛活性。此外,确定了化合物的致溃疡风险。通常,与参考药物
布洛芬和
吲哚美辛相比,没有一种化合物具有发生胃部损伤的风险。带有3-苯基-2-
丙烯基(1a),(
联苯基-4-基)亚甲基(1f)和(1-甲基
吡咯-2-基)亚甲基(1n)的化合物)在稠环的第6位被评估为潜在的止痛/抗炎药,没有胃肠道副作用。因此,这些新化合物值得进一步关注以开发新的先导药物。